PDCD1 and cancer: In term of single PD-1/PD-L1 inhibitors, both OS and PFS were similar between patients treated with PD-1/PD-L1 inhibitors and those treated with SOC, regardless of cancer types (Supplementary Figure S14A, C; Supplementary Figure S15, 16).